Navigation Links
Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in California's Central Valley
Date:2/4/2009

Foundation to implement advanced patient outcome analysis software to monitor health outcomes in Fresno, California

LOS ALTOS, Calif., Feb. 4 /PRNewswire-USNewswire/ -- Global Health Research Foundation (GHRF) today announced that it has received a $25,000 grant from the Westly Foundation to fund asthma treatment in California's Central Valley, a region with the highest level of asthma cases in the state. The grant will help fund data collection and analysis at community clinics to better focus scarce resources on the most severe asthma cases. The data will also be used in a study of children's asthma and pollution levels conducted by the Stanford University School of Medicine. "Asthma cases have more than doubled in the state since 1996. With our grant, we hope to help turn this around," commented Steve Westly, co-founder of the Westly Foundation, a private family foundation.

GHRF will implement sophisticated patient outcome analysis software, called Solutions, in two clinics in Fresno, CA, a city the American Lung Association named the third most polluted in the nation. "A significant group of patients has trouble managing asthma, so they end up suffering unnecessarily and require expensive intervention such as emergency room visits. The data generated by Solutions will identify these patients so they can receive assistance managing their asthma," explained Dr. Erica Weirich, director of GHRF. The Westly Foundation grant will also fund "promotores," or community health workers, who will train and support patients identified as at-risk. Over time, these steps should significantly reduce costs while improving patient health.

Solutions will also provide important data to a research project undertaken by Dr. Kari Nadeau, an assistant professor of pediatrics at Stanford University and Lucile Packard Children's Hospital. The project plans to analyze clinic
'/>"/>

SOURCE Global Health Research Foundation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand
2. Isogen Launches Major New Facility to Address Global Biopharma Demand
3. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
4. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
5. NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting
6. Clinton Global Initiative Announces BDs Commitment to Biamba Marie Mutombo Hospital
7. NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference
8. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
9. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
10. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
11. ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...ewswire/ -- FUJIFILM Medical Systems USA, Inc. is ...y flat panel DR cassette, at the 2009 Radiological...Ideal for any clinical environment, FDR D-EVO uses...s with Fujifilm,s trademark image quality and outs...for users to transition to DR without modification...
(Date:11/29/2009)...ewswire/ -- Stimulated by the ten years of Synapse... Systems USA announced today, at the Radiological ...e formation of its Medical Informatics Division ....up will integrate all functions associated with th...tform for future growth. ,, Several organizatio...
(Date:11/29/2009)...ewswire/ -- Researchers using functional magnetic ... have found that men and women respond differently...study presented today at the annual meeting of the..., "Men may direct more attention to sensory aspec...n terms of implications for required action, where...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3New Jersey Dietetic Association Names Ketchums Jaime Schwartz Young Dietitian of the Year 52263 1New Jersey Dietetic Association Names Ketchums Jaime Schwartz Young Dietitian of the Year 52263 2New Jersey Dietetic Association Names Ketchums Jaime Schwartz Young Dietitian of the Year 52263 3Tips from the journals of the American Society for Microbiology 52258 1Tips from the journals of the American Society for Microbiology 52258 2Tips from the journals of the American Society for Microbiology 52258 3Tips from the journals of the American Society for Microbiology 52258 4Life on Earth came from other planets 9299 1Life on Earth came from other planets 9299 2Life on Earth came from other planets 9299 3Life on Earth came from other planets 9299 4
...to Explore the Efficacy of Novel Proteasome Inhibi...ry Multiple Myeloma, SOUTH SAN FRANCISCO, Calif. ...Research Consortium (MMRC) and Proteolix, Inc. tod...n a multi-center Phase 2,clinical trial to study P...or, carfilzomib (PR-171), in patients with relapse...
...nn., Aug. 15 Kevin McHale is,one of five board me..., a,non-profit organization incorporated in Saint ...sperson. HMH was created to gift cochlear implants... never be able to obtain one.,Dr. William House, t...its,on the Board of Directors., While the burden ...
Other Medicine Technology:The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4Kevin McHale Instrumental in Forming the 'Help Me Hear Foundation' 2
(Date:11/27/2009)... GSI Group Inc. (Pink She...n technology products and semiconductor systems, t...ny,s shareholders has been scheduled for Friday, A...ng will be announced in due course. As previously...ice from Stephen Bershad, a holder of greater than...
(Date:11/27/2009)...m Replikins Ltd. today issued its latest biochemic...ows that the lethality of the virus has dropped fr...urrent outbreak in the spring of 2009 to resting n...e H1N1 infectivity count, however, remains increas...mber 27, 2009 -- Biotech firm Replikins Ltd., whic...
(Date:11/27/2009)...Newswire-FirstCall/ -- The Gymboree Corporation (N...OO, will present at the NASDAQ OMX 23rd Investor P...n London, England, on Wednesday, December 2, 2009,...dcast of The Gymboree Corporation,s presentation o...m, click on "Our Company" at the bottom of the pag...
(Date:11/27/2009)...ce, Nov. 27 Team Garmin-Slipstream...icated to ethical sporting and developing the next...that it will become Team Garmin-Transitions with t...r of the team. Transitions Optical is the world,s ... the most advanced photochromic technology in the ...
(Date:11/27/2009)...ldings has announced that it has become a national...argest nonprofit organizations dedicated to arthri... Delray Beach, FL (Vocus) Novemb...O), a company specializing in the marketing and re... has announced today that is has become a national...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4
...ide web foundation for the newly launched "indepen... Univita Health, a new company aimed at promoting...ndent aging, announced the acquisition of ENURGI, ... a virtual marketplace for individuals to find pro...
...fers quick-reference materials and multimedia tool...owing a child,s diagnosis , , BRIDGEWATER, N.J., ...ailability of the diabetes KidCare Kit, a multimed...st 30 days following a diagnosis of type 1 diabete...
...s the best way of spotting trouble, experts say , ...r versions of the stool-based colon cancer tests -...ry widely in their ability to spot potential abnor...e undetectable traces of blood that could come fro...
...Feb. 3 SuperGen, Inc. (Nasdaq: SUPG ), a pharma...velopment of novel cancer therapies, today announc...f Executive Officer, is scheduled to present at th...r Conference is scheduled to begin at 11:30 a.m. E...
...d Living Made Easy and Delicious with New Yoplait ... Probiotic Cultures , , MINNEAPOLIS, Feb. 3 Prob...th the latest flavor craze in the launch of Yoplai...men are familiar with probiotics, a strong indicat...
...Feb. 3 Alsius Corporation (Nasdaq: ALUS ), the ...gement (IVTM(TM)) therapies for critically ill pat...ond aggressively to the patent lawsuit brought aga...ement patents ZOLL purchased from a defunct compet...
Other Medicine News:Health News:Univita Health Acquires Leading Web Services Company 2Health News:New Diabetes Resource Provides Tools and Support to Families of Newly-Diagnosed Children with Type 1 Diabetes 2Health News:New Diabetes Resource Provides Tools and Support to Families of Newly-Diagnosed Children with Type 1 Diabetes 3Health News:New Diabetes Resource Provides Tools and Support to Families of Newly-Diagnosed Children with Type 1 Diabetes 4Health News:Stool-Based Colon Cancer Tests Vary Widely in Accuracy 2Health News:Stool-Based Colon Cancer Tests Vary Widely in Accuracy 3Health News:SuperGen to Present at BIO CEO & Investor Conference on February 10, 2009 2Health News:Flavor and Function Are a Hot Match in 2009... Located In a Cool Place 2Health News:ALSIUS CORPORATION PREPARED TO INVALIDATE ZOLL TEMPERATURE MANAGEMENT PATENTS 2
Thermal Transfer Wristbands
Patient-ID™
...I-MATCH III is a label-based patient ID system whi...ification System, an admitting band and up to six ...e only ID band worn by hospital patients. It integ...or blood banks into a multipurpose ID band that co...
Zebra H 2824-Z Healthcare Starter Kit
Medicine Products: